I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an "inconvenient" truth?

FA Verburg, L Giovanella, I Iakovou, Mark Konijnenberg, W Langsteger, M Lassmann, J Mihailovic, M Luster

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2247-2249
Number of pages3
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Issue number13
Publication statusPublished - 2018

Cite this